Salmeterol Xinafoate API

Name	Salmeterol xinafoate
Chinese name	昔萘酸沙美特罗
Cas Number	94749-08-3
Source	India/Switzerland
Qualifications	USDMF/-/-/-/-

Salmeterol xinafoate is a long-lasting and highly selective β2 adrenergic receptor agonist developed by GlaxoSmithKline. It has obvious bronchodilator effect and is used for long-term routine treatment of reversible respiratory tract of asthma. Obstruction and chronic bronchitis can also be used for patients who need to routinely use bronchodilators, and prevent nighttime asthma attacks or control daytime asthma instability. Different from other bronchodilator drugs, salmeterol xinafoate has higher lipophilicity and unique pharmacodynamic characteristics. Its dosage is very small, and the effect is long-lasting, which can produce longer lasting bronchodilation for at least 12 hours effect. Salmeterol xinafoate has the characteristics of long duration of action, small extrapulmonary action, and good tolerability. It is currently an ideal drug for the treatment of nighttime asthma attacks and maintenance treatment of asthma. In 2018, global sales were 22 billion yuan. In 2018, the sales of salmeterol ticasone powder inhalants in China's public medical institutions were 1.563 billion yuan, a year-on-year increase of 10%.

Hot Tags: salmeterol xinafoate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Tetrabenazine API, Apremilast API, Temozolomide API, Aprepitant Aprepitant API, Adapalene API, Paliperidone API

• Previous: Fondaparinux API
• Next: Valganciclovir Hydrochloride API